Status:
COMPLETED
CIRSE Registry for SIR-Spheres in France (CIRT-FR)
Lead Sponsor:
Cardiovascular and Interventional Radiological Society of Europe
Conditions:
Liver Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Selective Internal Radiation Therapy (SIRT), also known as radioembolisation, is a minimal invasive, endovascular treatment for primary and secondary liver tumours. In France, SIR-Spheres are listed a...
Detailed Description
Selective internal radiation therapy (SIRT), also called radioembolisation (RE), with SIR-Spheres microspheres is an endovascular procedure, included within the interventional oncologic technologies t...
Eligibility Criteria
Inclusion
- 18 years or older
- Primary or secondary liver tumours
- Treatment of liver tumours with SIR-Spheres
- Signed informed consent form
Exclusion
- \- Consent denied
Key Trial Info
Start Date :
August 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2022
Estimated Enrollment :
332 Patients enrolled
Trial Details
Trial ID
NCT03256994
Start Date
August 1 2017
End Date
July 31 2022
Last Update
August 15 2022
Active Locations (13)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU d'Angers
Angers, France
2
CHU de Bordeaux
Bordeaux, France
3
Hôpital Beaujon
Clichy, France
4
Hôpital Henri Mondor
Créteil, France